HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Pharmacologic Treatments for COVID-19

During corona virus, the FDA has issued an emergency use authorization (EUA) for bamlanivimab, which is a monoclonal antibody given against the spike protein of SARS-CoV-2

Baricitinib or JAK inhibitor is used in combination with remdesivir, in the treatment of suspected or laboratory-confirmed coronavirus disease in hospitalized patients aged 2 years and elderly who require supplemental oxygen, invasive mechanical ventilation. Various other antiviral agents, immunotherapies, and vaccines continue to be investigated and developed as possible therapies.

Committee Members
Speaker at Pharmaceutical Conference - Thomas J. Webster

Thomas J. Webster

Mansfield Bioincubator, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Pharma Conferences - Saad Tayyab

Saad Tayyab

UCSI University, Malaysia
PDDS 2024 Speakers

Submit your abstract Today